HAIC means HAIC, also known as hepatic arterial chemoembolization, which refers to the delivery of drugs directly to the tumor blood-supplying arteries via hepatic artery cannulation by interventional techniques, mainly for hepatocellular carcinoma.
HAIC is mainly suitable for treating patients with advanced unresectable hepatocellular carcinoma, recurrence after treatment by arterial chemoembolization, diffuse type or combined with portal vein cancer embolism.
Theoretically HAIC is used to maximize the killing effect by continuous infusion of high concentrations of cytotoxicity to the tumor through the hepatocytes, without causing major adverse effects on normal cellular liver tissue. In addition, because the drug passes first through the liver, it rarely produces systemic adverse effects.
In recent years, HAIC has shown good efficacy in patients with liver metastatic cancer, especially colorectal cancer liver metastasis.